| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other income, net | 6,242 | 6,472 | 7,804 | 8,264 |
| Net loss | -74,149 | -70,375 | -77,065 | -88,105 |
| Unrealized holding gain | 656 | -201 | 1,029 | 3,849 |
| Total other comprehensive income | 656 | -201 | 1,029 | 3,849 |
| Total comprehensive loss | -73,493 | -70,576 | -76,036 | -84,256 |
| Net loss per share, basic | -0.43 | -0.41 | -0.46 | -0.63 |
| Net loss per share, diluted | -0.43 | -0.41 | -0.46 | -0.63 |
| Weighted average shares of common stock, basic | 172,389,209 | 171,264,622 | 169,233,155 | 140,229,056 |
Relay Therapeutics, Inc. (RLAY)
Relay Therapeutics, Inc. (RLAY)